Search research articles
Contact Us
Filters
Showing results (41-50 of 414) with videos related to
Page
of 42
Sort By:
JAMA Internal Medicine
|
September 7, 2016
Fish Oils and Bleeding-Where Is the Evidence?-Reply
Dima M Qato, G Caleb Alexander
Journal of General Internal Medicine
|
July 12, 2012
Just because it's low cost doesn't mean it's accessible
Dima M Qato, G Caleb Alexander
JAMA Network Open
|
September 6, 2024
Managing Drug-Drug Interactions-So Many Drugs, So Little Evidence
Hemalkumar B Mehta, G Caleb Alexander
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 1, 2011
Unsupported off-label use of cancer therapies: new challenges in the era of biopharmaceuticals
Jonas A de Souza, G Caleb Alexander
Health Services Research
|
December 17, 2009
Impact of Medicare Part D on Medicare-Medicaid dual-eligible beneficiaries' prescription utilization and expenditures
Anirban Basu, Wesley Yin, G Caleb Alexander
Journal of General Internal Medicine
|
October 3, 2020
The United States Postal Service: an Essential Public Health Agency?
Syed M Qasim Hussaini, G Caleb Alexander
Journal of the National Medical Association
|
August 10, 2010
Academic medical centers and underserved communities: modern complexities of an enduring relationship
Allison Lale, Rachael Moloney, G Caleb Alexander
Medical Care
|
March 26, 2008
Characteristics of patients receiving pharmaceutical samples and association between sample receipt and out-of-pocket prescription costs
G Caleb Alexander, James Zhang, Anirban Basu
JAMA
|
July 11, 2013
The Food and Drug Administration Amendments Act and postmarketing commitments
Kevin Fain, Matthew Daubresse, G Caleb Alexander
Medical Care
|
April 15, 2017
Patterns of Buprenorphine-Naloxone Treatment for Opioid Use Disorder in a Multistate Population
Brendan Saloner, Matthew Daubresse, G Caleb Alexander
Page
of 42
Search research articles
Search
Showing results (41-50 of 414) with videos related to
Sort By:
Page
of 42
JAMA Internal Medicine
|
September 7, 2016
Fish Oils and Bleeding-Where Is the Evidence?-Reply
Dima M Qato, G Caleb Alexander
Journal of General Internal Medicine
|
July 12, 2012
Just because it's low cost doesn't mean it's accessible
Dima M Qato, G Caleb Alexander
JAMA Network Open
|
September 6, 2024
Managing Drug-Drug Interactions-So Many Drugs, So Little Evidence
Hemalkumar B Mehta, G Caleb Alexander
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 1, 2011
Unsupported off-label use of cancer therapies: new challenges in the era of biopharmaceuticals
Jonas A de Souza, G Caleb Alexander
Health Services Research
|
December 17, 2009
Impact of Medicare Part D on Medicare-Medicaid dual-eligible beneficiaries' prescription utilization and expenditures
Anirban Basu, Wesley Yin, G Caleb Alexander
Journal of General Internal Medicine
|
October 3, 2020
The United States Postal Service: an Essential Public Health Agency?
Syed M Qasim Hussaini, G Caleb Alexander
Journal of the National Medical Association
|
August 10, 2010
Academic medical centers and underserved communities: modern complexities of an enduring relationship
Allison Lale, Rachael Moloney, G Caleb Alexander
Medical Care
|
March 26, 2008
Characteristics of patients receiving pharmaceutical samples and association between sample receipt and out-of-pocket prescription costs
G Caleb Alexander, James Zhang, Anirban Basu
JAMA
|
July 11, 2013
The Food and Drug Administration Amendments Act and postmarketing commitments
Kevin Fain, Matthew Daubresse, G Caleb Alexander
Medical Care
|
April 15, 2017
Patterns of Buprenorphine-Naloxone Treatment for Opioid Use Disorder in a Multistate Population
Brendan Saloner, Matthew Daubresse, G Caleb Alexander
Page
of 42